Metabolic dysfunction-associated fatty liver disease from definition to complications | ||||
| Medical Journal of Viral Hepatitis | ||||
| Article 2, Volume 6.1, Issue 1, December 2021, Page 4-9 PDF (584.53 K) | ||||
| Document Type: Review articles | ||||
| DOI: 10.21608/mjvh.2021.211705 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
Ahmed Ezzat  1; Mohammad Elmoghazy2
| ||||
| 1Tropical medicine department, Mansoura faculty of medicine | ||||
| 2Damietta Cardiology and Gastroenterology Center, Damietta, Egypt. | ||||
| Abstract | ||||
| Metabolic dysfunction-associated fatty liver disease (MAFLD) is a novel term to describe new diagnostic criteria for diagnosing fatty liver disease free of alcohol intake and associated viral hepatitis infection. These new diagnostic criteria, make it easier to diagnose than non-alcoholic fatty liver disease (NAFLD). Although we may not have a lot of studies about MAFLD yet, we have plenty of evidence about IR, metabolic syndrome and dysfunction, and NAFLD. In this review, we try to spotlight some important and updated knowledge about MAFLD and its related conditions, to help us better understand and deal with this global problem. | ||||
| Keywords | ||||
| Metabolic dysfunction-associated fatty liver disease; non-alcoholic fatty liver disease; insulin resistance | ||||
|
Statistics Article View: 171 PDF Download: 1,284 |
||||
